Lv51
1090 积分 2023-12-13 加入
Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
1小时前
待确认
Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer
1小时前
待确认
Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression
1天前
待确认
Phocaeicola vulgatus induces immunotherapy resistance in hepatocellular carcinoma via reducing indoleacetic acid production
1天前
待确认
Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses
1天前
待确认
The gut microbiota in cancer immunity and immunotherapy
1天前
待确认
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma
1天前
待确认
Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells
2天前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
2天前
已完结
Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy
2天前
已完结
皖公网安备34019202002308
